Health Science

In Human Clinical Trial, UAB to Test Drug Shown to Completely Reverse Diabetes in Human Islets, Mice
New research conducted at the University of Alabama at Birmingham has shown that the common blood pressure drug verapamil completely reverses diabetes in animal models. Now, thanks to a three-year, $2.1 million grant from the JDRF, UAB researchers will begin conducting a potentially groundbreaking clinical trial in 2015 to see if it can do the same in humans.

A novel jelly-like substance developed by Kansas State University researchers was recently issued a U.S. patent. The substance may be used for biomedical applications, ranging from cell culture and drug delivery to repairing and replacing tissue, organs and cartilage.

As children, it was fascinating to put a flashlight up to our palms to see the light shine through the hand. Washington University in St. Louis engineers are using a similar idea to track movement inside the body’s tissues to improve imaging of cancerous tissues and to develop potential treatments.

"Patenting a gene is like patenting the water we drink and the air we breathe," says hospital's CEO.

Scientists at EPFL have used a new imaging technique to monitor how glucose, our main energy source, is used in the body. Their findings may have great implications for diseases like diabetes.














